News FDA unveils framework for its expedited IND pilot The FDA has published the design of its expedited Investigational New Drug pilot, part of a plan to restore US competitiveness in clinical research.
News Pharma body sees 'green shoots' in UK investment The UK is starting to benefit from a "real partnership" between pharma and government, reversing years of diminishing investment, says the ABPI.
News HHS details plan to regain the US's edge in clinical trials The US launches a concerted effort to "restore American leadership in clinical trials" as it deals with the emergence of China as a global R&D hub.
News Euro VCs team up to invigorate life sciences ecosystem Major venture capital groups in Europe have joined forces to set up a new coalition aimed at revitalising access to life sciences investment.
News Novartis issues a life sciences warning in a 'G-Zero' world Novartis claims life sciences lie at the centre of a shift in geopolitics and policies in regions like Europe, Japan, and Canada are "self-defeating."
News US vulnerable to China's API dominance, says report China has such a dominant position in pharmaceutical ingredient production that there is a risk it will weaponise access, says a Congressional report.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.